PlexBio Co., Ltd. (TPEX:6572)

PlexBio Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	127.1	128.06	167.18	191.19	124.94
Revenue Growth (YoY)	-0.76%	-23.40%	-12.56%	53.02%	23.28%
Cost of Revenue	86.68	78.8	104.71	132.19	86.38
Gross Profit	40.41	49.26	62.47	59	38.56
Selling, General & Admin	53.56	59.5	63.65	53.32	60.51
Research & Development	52.5	69.29	62.97	72.61	113.31
Operating Expenses	106.06	128.79	126.62	125.93	173.82
Operating Income	-65.65	-79.53	-64.15	-66.94	-135.26
Interest Expense	-0.27	-0.16	-0.26	-0.17	-0.23
Interest & Investment Income	7.99	9.58	8.27	3.01	2.31
Currency Exchange Gain (Loss)	-	7.84	-2.88	10.06	-2.01
Other Non Operating Income (Expenses)	-4.55	0.63	0.49	0.9	4.08
EBT Excluding Unusual Items	-62.47	-61.63	-58.53	-53.14	-131.11
Gain (Loss) on Sale of Assets	-	-	-	-	-0.48
Pretax Income	-62.47	-61.63	-58.53	-53.14	-131.59
Net Income	-62.47	-61.63	-58.53	-53.14	-131.59
Net Income to Common	-62.47	-61.63	-58.53	-53.14	-131.59
Shares Outstanding (Basic)	104	104	104	104	104
Shares Outstanding (Diluted)	104	104	104	104	104
Shares Change (YoY)	0.45%	-	-	0.11%	0.51%
EPS (Basic)	-0.60	-0.59	-0.56	-0.51	-1.27
EPS (Diluted)	-0.60	-0.59	-0.56	-0.51	-1.27
Free Cash Flow	-79.52	-8.64	-32.11	-73.02	-95.94
Free Cash Flow Per Share	-0.76	-0.08	-0.31	-0.70	-0.93
Gross Margin	31.80%	38.46%	37.37%	30.86%	30.86%
Operating Margin	-51.65%	-62.10%	-38.38%	-35.01%	-108.26%
Profit Margin	-49.15%	-48.13%	-35.01%	-27.79%	-105.32%
Free Cash Flow Margin	-62.57%	-6.75%	-19.21%	-38.19%	-76.78%
EBITDA	-49.16	-69.67	-55.06	-55.76	-121.46
EBITDA Margin	-38.68%	-54.40%	-32.93%	-29.17%	-97.21%
D&A For EBITDA	16.49	9.86	9.09	11.17	13.8
EBIT	-65.65	-79.53	-64.15	-66.94	-135.26
EBIT Margin	-51.65%	-62.10%	-38.37%	-35.01%	-108.26%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.